Award details

Avipox Viromics

ReferenceBBS/E/I/00001019
Principal Investigator / Supervisor Professor Michael Skinner
Co-Investigators /
Co-Supervisors
Institution The Pirbright Institute
DepartmentThe Pirbright Institute Department
Funding typeResearch
Value (£) 754,046
StatusCompleted
TypeInstitute Project
Start date 01/04/2003
End date 31/10/2005
Duration31 months

Abstract

Although we intend to continue targeted study of specific candidate immunomodulators (IL-18bp and, should appropriate opportunities arise, the chemokine-like proteins), the major aim is to develop broad scale viromic approaches using genetics and biochemistry or cell biology. A primary target of the viromics is to develop genetic approaches to identify factors involved in resistance to type I interferon. In one approach, we will screen a bank of pan-genome knockouts for loss of trans-acting resistance to exogenous type I interferon. In a complementary approach, we will screen an expression library for complementation of a defect in resistance to type I interferon. Establishing the mutant bank and expression library will be a major part of the programme but will provide resources available for identification of genes involved in functions other than resistance to type I interferon. Work will continue on the yeast-2-hybrid analysis of interactions between selected FPV proteins and host proteins as well as between a random library of all FPV proteins. In particular, work will address the validity and role of interactions identified.

Summary

unavailable
Committee Closed Committee - Animal Sciences (AS)
Research TopicsX – not assigned to a current Research Topic
Research PriorityX – Research Priority information not available
Research Initiative X - not in an Initiative
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file